Table 3.
All patients (full cohort) |
Patients with estrogen receptor- and grade 3 tumors (restricted cohort) |
|||
---|---|---|---|---|
Medullary | Ductal | Medullary | Ductal | |
Total patients | 127 | 8096 | 47 | 1407 |
No DFS event | 58 (46) | 3577 (44) | 26 (55) | 642 (46) |
Breast cancer-related DFS events | 44 (35) | 3770 (47) | 14 (30) | 674 (48) |
Local | 6 (5) | 666 (8) | 0 | 94 (7) |
Contralateral breast | 7 (6) | 333 (4) | 4 (9) | 44 (3) |
Regional | 8 (6) | 493 (6) | 5 (11) | 116 (6) |
Distant (as first site) | 23 (18) | 2278 (28) | 5 (11) | 420 (30) |
Distant soft tissue | 4 (3) | 129 (2) | 0 | 33 (2) |
Bone | 6 (5) | 880 (11) | 1 (2) | 105 (7) |
Viscera | 13 (10) | 1269 (16) | 4 (9) | 282 (20) |
Non-breast cancer-related events | 25 (9) | 749 (29) | 7 (6) | 91 (15) |
Second primary non-breast | 12 (9) | 362 (4) | 3 (6) | 49 (3) |
Death without prior cancer event | 11 (9) | 360 (4) | 3 (6) | 39 (3) |
Unknown | 2 (2) | 27 (0.3) | 1 (2) | 3 (0.2) |